Today: 9 June 2026
AMC Stock Today (Nov 5, 2025): Q3 Revenue Beats Estimates, Loss Widens; CEO Sees Best Q4 in Six Years
5 November 2025
2 mins read

AMC Stock Today (Nov 5, 2025): Q3 Revenue Beats Estimates, Loss Widens; CEO Sees Best Q4 in Six Years

AMC Entertainment’s (NYSE: AMC) shares are in focus after the company posted third‑quarter results and struck an upbeat tone on year‑end box office momentum.

What happened today

AMC reported Q3 revenue of $1.30 billion, topping Wall Street’s ~$1.23 billion consensus, as summer and early fall releases kept moviegoers coming back. The company also booked a net loss of $298.2 million for the quarter, with management citing non‑cash items tied to its July debt transactions among the drivers. CEO Adam Aron said he expects the industry’s fourth quarter to be the highest‑grossing in six years and projected a materially larger 2026 box office versus 2025.

AMC filed its quarterly report this afternoon alongside the earnings news release, and hosted its webcast at 5:00 p.m. ET. The filing includes detailed segment and cash metrics and is available on the company’s investor site.


The numbers behind the headline

  • Revenue: $1.300 billion (vs. $1.349 billion in Q3’24).
  • GAAP net loss:$298.2 million; GAAP EPS:–$0.58.
  • Adjusted EBITDA:$122.2 million (vs. $161.8 million a year ago).
  • Adjusted EPS:–$0.21 (slightly worse than the –$0.19 consensus).
  • Cash & cash equivalents:$365.8 million at quarter‑end.

Management’s color ties the wider loss primarily to non‑cash charges associated with the company’s summer refinancing and related liability accounting in Q3.


Operating trends worth watching

  • Per‑patron spending: Food & beverage revenue per patron rose to $7.74 in Q3 (U.S. $8.55, International $5.61), reflecting pricing and attach‑rate improvements.
  • Blockbuster support: Revenue upside was helped by a lineup Reuters highlighted as including “Superman” and “The Conjuring: Last Rites.” Reuters
  • Q4 slate: Management spotlighted year‑end tentpoles and special events; coverage today referenced titles such as “Zootopia 2,” “Wicked: For Good,” and “Avatar: Fire and Ash,” with the company reiterating a strong fourth‑quarter outlook. Investing.com Australia

Stock reaction (intraday)

Shares traded near the $2–3 range as results crossed; coverage this evening noted the stock up about 1–2% after hours as investors digested the revenue beat and optimistic Q4 commentary (see real‑time chart above).


Balance sheet & share count

The 10‑Q shows 512,943,561 common shares outstanding as of Nov. 4, 2025. The filing also notes AMC currently has no remaining authorized common shares that are not already issued or reserved, a detail traders often track given the company’s history of equity raises.


Why it matters for AMC stock today

  • Beat where it counts: The top‑line beat suggests AMC is outpacing a still‑uneven release calendar, an incremental positive for sentiment around ticket and concession trends.
  • Costs and capital structure linger: A wider GAAP loss and continued interest expense underscore that leverage is still central to the equity story despite refinancing progress.
  • Guidance by implication, not numbers: While AMC didn’t issue formal Q4 guidance in the press materials, its “best Q4 in six years” comment sets an expectations bar investors will track against the holiday slate. Reuters

Quick Q&A

Did AMC beat earnings?
On revenue, yes; on adjusted EPS, AMC missed by about 2 cents (–$0.21 vs. –$0.19 est.).

Is per‑patron spending still rising?
Yes. F&B per patron hit $7.74 in Q3 (up from $7.53 a year ago), with U.S. and International both higher.

What’s next on the calendar?
Management held its earnings webcast at 5:00 p.m. ET today; a replay and the full 10‑Q are posted on AMC’s investor relations site.


Today’s primary sources

  • Reuters: Q3 revenue beat, CEO commentary on Q4 and 2026.
  • AMC IR / 10‑Q: Detailed financials, cash, share count, segment metrics.
  • Business Wire: Earnings announcement and webcast details.
  • Benzinga / Investing.com: Adjusted EPS consensus context, after‑hours price check, select management quotes and Q4 slate highlights.

This article is for informational purposes only and is not investment advice.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Upstart Holdings’ AI Lending Revolution: Surging Growth, Stock Turmoil, and What’s Next for UPST
Previous Story

Upstart Holdings’ AI Lending Revolution: Surging Growth, Stock Turmoil, and What’s Next for UPST

Interstellar Comet 3I/ATLAS: A Visitor from Beyond the Solar System
Next Story

Comet 3I/ATLAS today (6 Nov 2025): China’s Mars orbiter snaps new photos as the interstellar visitor turns bluer and shows puzzling acceleration

Go toTop